{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T23:05:21Z","timestamp":1794265521291,"version":"4.9.0"},"reference-count":148,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DK135815"],"award-info":[{"award-number":["R01DK135815"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DK140485"],"award-info":[{"award-number":["R01DK140485"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["517010379"],"award-info":[{"award-number":["517010379"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["457840828"],"award-info":[{"award-number":["457840828"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jhep.2025.05.009","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T02:46:32Z","timestamp":1747968392000},"page":"1204-1217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Enteronephrohepatic circulation of bile acids and therapeutic potential of systemic bile acid transporter inhibitors"],"prefix":"10.1016","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0695-3403","authenticated-orcid":false,"given":"Ahmed","family":"Ghallab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattias","family":"Mandorfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3447-264X","authenticated-orcid":false,"given":"Guido","family":"Stirnimann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Geyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Lindstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6288-8821","authenticated-orcid":false,"given":"Tom","family":"Luedde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Schalk","family":"van der Merwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8216-0064","authenticated-orcid":false,"given":"Jassin","family":"Rashidi-Alavijeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saul J.","family":"Karpen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Fickert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1275-6425","authenticated-orcid":false,"given":"Michael","family":"Trauner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1427-5246","authenticated-orcid":false,"given":"Jan G.","family":"Hengstler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9760-4422","authenticated-orcid":false,"given":"Paul A.","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2025.05.009_bib1","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1124\/dmd.121.000643","article-title":"Molecular regulation of bile acid homeostasis","volume":"50","author":"Choudhuri","year":"2022","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jhep.2025.05.009_bib2","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jhep.2021.02.011","article-title":"Bile formation and secretion: an update","volume":"75","author":"Boyer","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.05.009_bib3","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1002\/hep.28991","article-title":"New therapeutic concepts in bile acid transport and signaling for management of cholestasis","volume":"65","author":"Trauner","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.05.009_bib4","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1194\/jlr.R900012-JLR200","article-title":"Bile acid transporters","volume":"50","author":"Dawson","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jhep.2025.05.009_bib5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jhep.2012.08.002","article-title":"Bile acid transporters and regulatory nuclear receptors in the liver and beyond","volume":"58","author":"Halilbasic","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.05.009_bib6","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.bbadis.2018.05.011","article-title":"Animal models to study bile acid metabolism","volume":"1865","author":"Li","year":"2019","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.jhep.2025.05.009_bib7","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1172\/JCI119816","article-title":"Rat cholangiocytes absorb bile acids at their apical domain via the ileal sodium-dependent bile acid transporter","volume":"100","author":"Lazaridis","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2025.05.009_bib8","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/hep.20961","article-title":"OSTalpha-OSTbeta: a major basolateral bile acid and steroid transporter in human intestinal, renal, and biliary epithelia","volume":"42","author":"Ballatori","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.05.009_bib9","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1053\/j.gastro.2012.04.036","article-title":"A cholecystohepatic shunt pathway: does the gallbladder protect the liver?","volume":"142","author":"Boyer","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2025.05.009_bib10","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1172\/JCI119355","article-title":"Primary bile acid malabsorption caused by mutations in the ileal sodium-dependent bile acid transporter gene (SLC10A2)","volume":"99","author":"Oelkers","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2025.05.009_bib11","doi-asserted-by":"crossref","first-page":"33920","DOI":"10.1074\/jbc.M306370200","article-title":"Targeted deletion of the ileal bile acid transporter eliminates enterohepatic cycling of bile acids in mice","volume":"278","author":"Dawson","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2025.05.009_bib12","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1073\/pnas.0712328105","article-title":"The organic solute transporter alpha-beta, Ostalpha-Ostbeta, is essential for intestinal bile acid transport and homeostasis","volume":"105","author":"Rao","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2025.05.009_bib13","doi-asserted-by":"crossref","first-page":"G179","DOI":"10.1152\/ajpgi.90319.2008","article-title":"Ostalpha-Ostbeta is required for bile acid and conjugated steroid disposition in the intestine, kidney, and liver","volume":"295","author":"Ballatori","year":"2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2025.05.009_bib14","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1194\/jlr.R054114","article-title":"Intestinal transport and metabolism of bile acids","volume":"56","author":"Dawson","year":"2015","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jhep.2025.05.009_bib15","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1152\/ajplegacy.1964.207.5.964","article-title":"Renal excretion of bile acids: taurocholic, glycocholic, and colic acids","volume":"207","author":"Weiner","year":"1964","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jhep.2025.05.009_bib16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1042\/bj1660065","article-title":"The role of tubular reabsorption in the renal excretion of bile acids","volume":"166","author":"Barnes","year":"1977","journal-title":"Biochem J"},{"key":"10.1016\/j.jhep.2025.05.009_bib17","first-page":"51","article-title":"Evidence for renal control of urinary excretion of bile acids and bile acid sulphates in the cholestatic syndrome","volume":"52","author":"Summerfield","year":"1977","journal-title":"Clin Sci Mol Med"},{"key":"10.1016\/j.jhep.2025.05.009_bib18","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1042\/cs0610773","article-title":"Urinary excretion of bile acids in cholestasis: evidence for renal tubular secretion in man","volume":"61","author":"Corbett","year":"1981","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.jhep.2025.05.009_bib19","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1172\/JCI110668","article-title":"Hepatic uptake of bile acids in man. Fasting and postprandial concentrations of individual bile acids in portal venous and systemic blood serum","volume":"70","author":"Angelin","year":"1982","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2025.05.009_bib20","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0016-5085(85)80144-X","article-title":"Serum concentrations of ursodeoxycholic acid in portal venous and systemic venous blood of fasting humans as determined by isotope dilution-mass spectrometry","volume":"88","author":"Ewerth","year":"1985","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2025.05.009_bib21","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0022-2275(20)38054-8","article-title":"Hepatic bile acid uptake: effect of conjugation, hydroxyl and keto groups, and albumin binding","volume":"23","author":"Aldini","year":"1982","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jhep.2025.05.009_bib22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1365-2362.1974.tb00373.x","article-title":"Bile salt sulphates in cholestasis","volume":"4","author":"Stiehl","year":"1974","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jhep.2025.05.009_bib23","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jcmgh.2020.02.005","article-title":"A physiology-based model of bile acid distribution and metabolism under healthy and pathologic conditions in human beings","volume":"10","author":"Voronova","year":"2020","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2025.05.009_bib24","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jhep.2009.05.012","article-title":"New molecular insights into the mechanisms of cholestasis","volume":"51","author":"Wagner","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.05.009_bib25","doi-asserted-by":"crossref","first-page":"433","DOI":"10.4254\/wjh.v13.i4.433","article-title":"Bile acid indices as biomarkers for liver diseases I: diagnostic markers","volume":"13","author":"Alamoudi","year":"2021","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jhep.2025.05.009_bib26","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1055\/s-0030-1253225","article-title":"Nuclear receptor regulation of the adaptive response of bile acid transporters in cholestasis","volume":"30","author":"Wagner","year":"2010","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2025.05.009_bib27","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1002\/hep.24148","article-title":"Nuclear receptors in liver disease","volume":"53","author":"Wagner","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.05.009_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/cells13151296","article-title":"PPAR-mediated bile acid glucuronidation: therapeutic targets for the treatment of cholestatic liver diseases","volume":"13","author":"Gallucci","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.jhep.2025.05.009_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080994","article-title":"Role of glucuronidation for hepatic detoxification and urinary elimination of toxic bile acids during biliary obstruction","volume":"8","author":"Perreault","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2025.05.009_bib30","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8096314","article-title":"Urinary elimination of bile acid glucuronides under severe cholestatic situations: contribution of hepatic and renal glucuronidation reactions","volume":"2018","author":"Perreault","year":"2018","journal-title":"Can J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2025.05.009_bib31","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0016-5085(75)80093-X","article-title":"Sulfation and renal excretion of bile salts in patients with cirrhosis of the liver","volume":"68","author":"Stiehl","year":"1975","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2025.05.009_bib32","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/BF01313580","article-title":"Altered bile acid metabolism in primary biliary cirrhosis","volume":"26","author":"Raedsch","year":"1981","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2025.05.009_bib33","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/toxsci\/kfu228","article-title":"Urinary bile acids as biomarkers for liver diseases II. Signature profiles in patients","volume":"143","author":"Bathena","year":"2015","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.jhep.2025.05.009_bib34","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0304-4165(95)00023-5","article-title":"Binding of lithocholate and its glucuronide and sulfate by human serum albumin","volume":"1244","author":"Takikawa","year":"1995","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jhep.2025.05.009_bib35","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/hep.1840120419","article-title":"Transport of chenodeoxycholic acid and its 3-alpha- and 7-alpha-sulfates by isolated perfused rat liver","volume":"12","author":"Gartner","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.05.009_bib36","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1172\/JCI110128","article-title":"Sodium-coupled taurocholate transport in the proximal convolution of the rat kidney in vivo and in vitro","volume":"67","author":"Wilson","year":"1981","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2025.05.009_bib37","first-page":"G377","article-title":"Comparative analysis of the ontogeny of a sodium-dependent bile acid transporter in rat kidney and ileum","volume":"271","author":"Christie","year":"1996","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jhep.2025.05.009_bib38","first-page":"G157","article-title":"Expression and transport properties of the human ileal and renal sodium-dependent bile acid transporter","volume":"274","author":"Craddock","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jhep.2025.05.009_bib39","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1007\/BF01535786","article-title":"Intestinal absorption of bile acid glucuronides in rats","volume":"33","author":"Oelberg","year":"1988","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2025.05.009_bib40","first-page":"G34","article-title":"Effects of sulfation patterns on intestinal transport of bile salt sulfate esters","volume":"238","author":"De Witt","year":"1980","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jhep.2025.05.009_bib41","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1289\/ehp.793379","article-title":"Properties and biological significance of the ileal bile salt transport system","volume":"33","author":"Lack","year":"1979","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.jhep.2025.05.009_bib42","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/s41588-023-01409-8","article-title":"Genetic studies of paired metabolomes reveal enzymatic and transport processes at the interface of plasma and urine","volume":"55","author":"Schlosser","year":"2023","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2025.05.009_bib43","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41586-023-05769-3","article-title":"An atlas of healthy and injured cell states and niches in the human kidney","volume":"619","author":"Lake","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2025.05.009_bib44","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.devcel.2019.10.005","article-title":"Single-cell profiling reveals sex, lineage, and regional diversity in the mouse kidney","volume":"51","author":"Ransick","year":"2019","journal-title":"Dev Cell"},{"key":"10.1016\/j.jhep.2025.05.009_bib45","first-page":"1330","article-title":"Validation of NBD-coupled taurocholic acid for intravital analysis of bile acid transport in liver and kidney of mice","volume":"23","author":"Ghallab","year":"2024","journal-title":"Excli j"},{"key":"10.1016\/j.jhep.2025.05.009_bib46","doi-asserted-by":"crossref","first-page":"26934","DOI":"10.1074\/jbc.M203803200","article-title":"Impaired organic anion transport in kidney and choroid plexus of organic anion transporter 3 (Oat3 (Slc22a8)) knockout mice","volume":"277","author":"Sweet","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2025.05.009_bib47","doi-asserted-by":"crossref","first-page":"15789","DOI":"10.1074\/jbc.M117.796516","article-title":"The drug transporter OAT3 (SLC22A8) and endogenous metabolite communication via the gut-liver-kidney axis","volume":"292","author":"Bush","year":"2017","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2025.05.009_bib48","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1124\/dmd.121.000486","article-title":"Endogenous plasma kynurenic acid in human: a newly discovered biomarker for drug-drug interactions involving organic anion transporter 1 and 3 inhibition","volume":"49","author":"Tang","year":"2021","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jhep.2025.05.009_bib49","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/cpt.2630","article-title":"Blockade of organic anion transport in humans after treatment with the drug probenecid leads to major metabolic alterations in plasma and urine","volume":"112","author":"Granados","year":"2022","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jhep.2025.05.009_bib50","doi-asserted-by":"crossref","first-page":"p49","DOI":"10.1159\/000074330","article-title":"Regulation of renal tubular bile acid transport in the early phase of an obstructive cholestasis in the rat","volume":"95","author":"Schlattjan","year":"2003","journal-title":"Nephron Physiol"},{"key":"10.1016\/j.jhep.2025.05.009_bib51","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1042\/bj1560339","article-title":"Synthesis of bile acid monosulphates by the isolated perfused rat kidney","volume":"156","author":"Summerfield","year":"1976","journal-title":"Biochem J"},{"key":"10.1016\/j.jhep.2025.05.009_bib52","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1124\/mol.104.010587","article-title":"Analysis of the in vivo functions of Mrp3","volume":"68","author":"Belinsky","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jhep.2025.05.009_bib53","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/hep.21158","article-title":"Mrp4-\/- mice have an impaired cytoprotective response in obstructive cholestasis","volume":"43","author":"Mennone","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.05.009_bib54","doi-asserted-by":"crossref","first-page":"G1124","DOI":"10.1152\/ajpgi.00539.2005","article-title":"Upregulation of a basolateral FXR-dependent bile acid efflux transporter OSTalpha-OSTbeta in cholestasis in humans and rodents","volume":"290","author":"Boyer","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2025.05.009_bib55","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/hep.23265","article-title":"Mouse organic solute transporter alpha deficiency enhances renal excretion of bile acids and attenuates cholestasis","volume":"51","author":"Soroka","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.05.009_bib56","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1021\/mp060010s","article-title":"Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and therapeutic considerations","volume":"3","author":"Zollner","year":"2006","journal-title":"Mol Pharm"},{"key":"10.1016\/j.jhep.2025.05.009_bib57","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.gastro.2005.05.009","article-title":"Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans","volume":"129","author":"Marschall","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2025.05.009_bib58","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1053\/gast.2001.29608","article-title":"Adaptive regulation of bile salt transporters in kidney and liver in obstructive cholestasis in the rat","volume":"121","author":"Lee","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2025.05.009_bib59","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/hep.1840050325","article-title":"Biliary and urinary excretion of sulfated, glucuronidated and tetrahydroxylated bile acids in cirrhotic patients","volume":"5","author":"Stiehl","year":"1985","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.05.009_bib60","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5473752","article-title":"Urinary BA indices as prognostic biomarkers for complications associated with liver diseases","volume":"2022","author":"Li","year":"2022","journal-title":"Int J Hepatol"},{"key":"10.1016\/j.jhep.2025.05.009_bib61","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.jhep.2014.02.012","article-title":"Nod2 deficiency protects mice from cholestatic liver disease by increasing renal excretion of bile acids","volume":"60","author":"Wang","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.05.009_bib62","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1194\/jlr.M500427-JLR200","article-title":"Fxr(-\/-) mice adapt to biliary obstruction by enhanced phase I detoxification and renal elimination of bile acids","volume":"47","author":"Marschall","year":"2006","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jhep.2025.05.009_bib63","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/hep.25626","article-title":"Serotonin protects mouse liver from cholestatic injury by decreasing bile salt pool after bile duct ligation","volume":"56","author":"Jang","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.05.009_bib64","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1124\/dmd.106.009415","article-title":"Hepatic and extrahepatic synthesis and disposition of dinitrophenyl-S-glutathione in bile duct-ligated rats","volume":"34","author":"Villanueva","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jhep.2025.05.009_bib65","doi-asserted-by":"crossref","first-page":"F247","DOI":"10.1152\/ajprenal.00139.2008","article-title":"Adaptive responses of renal organic anion transporter 3 (OAT3) during cholestasis","volume":"295","author":"Chen","year":"2008","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1016\/j.jhep.2025.05.009_bib66","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jhep.2023.10.035","article-title":"Inhibition of the renal apical sodium dependent bile acid transporter prevents cholemic nephropathy in mice with obstructive cholestasis","volume":"80","author":"Ghallab","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.05.009_bib67","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/HEP.0000000000000376","article-title":"A3907, a systemic ASBT inhibitor, improves cholestasis in mice by multiorgan activity and shows translational relevance to humans","volume":"78","author":"Caballero-Camino","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.05.009_bib68","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jhep.2020.08.037","article-title":"Natural history of acute kidney disease in patients with cirrhosis","volume":"74","author":"Tonon","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.05.009_bib69","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ccc.2020.11.011","article-title":"Hepatorenal syndrome","volume":"37","author":"Khemichian","year":"2021","journal-title":"Crit Care Clin"},{"key":"10.1016\/j.jhep.2025.05.009_bib70","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jhep.2024.03.031","article-title":"Acute kidney injury in patients with cirrhosis: acute Disease Quality Initiative (ADQI) and International Club of Ascites (ICA) joint multidisciplinary consensus meeting","volume":"81","author":"Nadim","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.05.009_bib71","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/13696998.2019.1580201","article-title":"The burden of illness of hepatorenal syndrome (HRS) in the United States: a retrospective analysis of electronic health records","volume":"22","author":"Jamil","year":"2019","journal-title":"J Med Econ"},{"key":"10.1016\/j.jhep.2025.05.009_bib72","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41581-019-0218-4","article-title":"Reappraising the spectrum of AKI and hepatorenal syndrome in patients with cirrhosis","volume":"16","author":"Velez","year":"2020","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.jhep.2025.05.009_bib73","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.bbadis.2017.08.028","article-title":"Cholemic nephropathy - historical notes and novel perspectives","volume":"1864","author":"Krones","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.jhep.2025.05.009_bib74","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1055\/s-0039-1698826","article-title":"Cholemic nephropathy reloaded","volume":"40","author":"Fickert","year":"2020","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2025.05.009_bib75","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jhep.2023.11.008","article-title":"Detour of bile acid routes as therapeutic roadmap for cholemic nephropathy","volume":"80","author":"Fickert","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.05.009_bib76","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jhep.2017.02.019","article-title":"NorUrsodeoxycholic acid ameliorates cholemic nephropathy in bile duct ligated mice","volume":"67","author":"Krones","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.05.009_bib77","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1159\/000371689","article-title":"Bile acid-induced cholemic nephropathy","volume":"33","author":"Krones","year":"2015","journal-title":"Dig Dis"},{"key":"10.1016\/j.jhep.2025.05.009_bib78","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/ki.2013.78","article-title":"Bile cast nephropathy is a common pathologic finding for kidney injury associated with severe liver dysfunction","volume":"84","author":"van Slambrouck","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.jhep.2025.05.009_bib79","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1053\/j.akdh.2023.07.001","article-title":"Cholemic nephropathy: role in acute kidney injury in cholestasis and cirrhosis","volume":"31","author":"Pinter","year":"2024","journal-title":"Adv Kidney Dis Health"},{"key":"10.1016\/j.jhep.2025.05.009_bib80","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1111\/liv.15413","article-title":"Natural history, spectrum and outcome of stage 3 AKI in patients with acute-on-chronic liver failure","volume":"42","author":"Maiwall","year":"2022","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2025.05.009_bib81","doi-asserted-by":"crossref","first-page":"17","DOI":"10.34067\/KID.0005932020","article-title":"Bile acids are important contributors to AKI associated with liver disease: PRO","volume":"3","author":"Fickert","year":"2022","journal-title":"Kidney360"},{"key":"10.1016\/j.jhep.2025.05.009_bib82","doi-asserted-by":"crossref","first-page":"21","DOI":"10.34067\/KID.0006512020","article-title":"Bile acids are important contributors to AKI associated with liver disease: CON","volume":"3","author":"Allegretti","year":"2022","journal-title":"Kidney360"},{"key":"10.1016\/j.jhep.2025.05.009_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105311","article-title":"The pathogenesis of renal injury in obstructive jaundice: a review of underlying mechanisms, inducible agents and therapeutic strategies","volume":"163","author":"Liu","year":"2021","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jhep.2025.05.009_bib84","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1093\/ndt\/gfu046","article-title":"Interaction between systemic inflammation and renal tubular epithelial cells","volume":"29","author":"Cantaluppi","year":"2014","journal-title":"Nephrol Dial Transpl"},{"key":"10.1016\/j.jhep.2025.05.009_bib85","doi-asserted-by":"crossref","first-page":"48","DOI":"10.12703\/r\/10-48","article-title":"Recent advances in the understanding and management of hepatorenal syndrome","volume":"10","author":"Simbrunner","year":"2021","journal-title":"Fac Rev"},{"key":"10.1016\/j.jhep.2025.05.009_bib86","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1002\/hep.26599","article-title":"Bile acids trigger cholemic nephropathy in common bile-duct-ligated mice","volume":"58","author":"Fickert","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.05.009_bib87","series-title":"Dubin-johnson syndrome","author":"Talaga","year":"2024"},{"key":"10.1016\/j.jhep.2025.05.009_bib88","series-title":"GeneReviews((R)). Seattle (WA)","article-title":"Rotor syndrome","author":"Jirsa","year":"1993"},{"key":"10.1016\/j.jhep.2025.05.009_bib89","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/hep.27240","article-title":"Sodium taurocholate cotransporting polypeptide (SLC10A1) deficiency: conjugated hypercholanemia without a clear clinical phenotype","volume":"61","author":"Vaz","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.05.009_bib90","first-page":"4915","article-title":"Clinical and molecular characterization of four patients with NTCP deficiency from two unrelated families harboring the novel SLC10A1 variant c.595A>C (p.Ser199Arg)","volume":"20","author":"Li","year":"2019","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.jhep.2025.05.009_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2021.101824","article-title":"Sodium taurocholate co-transporting polypeptide deficiency","volume":"46","author":"Schneider","year":"2022","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.jhep.2025.05.009_bib92","article-title":"NTCP deficiency affects the levels of circulating bile acids and induces osteoporosis","volume":"13","author":"Yang","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jhep.2025.05.009_bib93","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jhep.2016.04.013","article-title":"First-in-human application of the novel hepatitis B and hepatitis D virus entry inhibitor myrcludex B","volume":"65","author":"Blank","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.05.009_bib94","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.bbamcr.2006.04.014","article-title":"Principles of hepatic organic anion transporter regulation during cholestasis, inflammation and liver regeneration","volume":"1773","author":"Geier","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jhep.2025.05.009_bib95","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/hep.30213","article-title":"Bile microinfarcts in cholestasis are initiated by rupture of the apical hepatocyte membrane and cause shunting of bile to sinusoidal blood","volume":"69","author":"Ghallab","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.05.009_bib96","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/hep.28965","article-title":"The ascending pathophysiology of cholestatic liver disease","volume":"65","author":"Jansen","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.05.009_bib97","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/hep.20653","article-title":"Secretin activation of the apical Na+-dependent bile acid transporter is associated with cholehepatic shunting in rats","volume":"41","author":"Alpini","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.05.009_bib98","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.3748\/wjg.v12.i22.3553","article-title":"Bile acid interactions with cholangiocytes","volume":"12","author":"Xia","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2025.05.009_bib99","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1053\/j.gastro.2012.02.033","article-title":"Defects in gallbladder emptying and bile Acid homeostasis in mice with cystic fibrosis transmembrane conductance regulator deficiencies","volume":"142","author":"Debray","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2025.05.009_bib100","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.1074\/jbc.RA119.011032","article-title":"S-acylation modulates the function of the apical sodium-dependent bile acid transporter in human cells","volume":"295","author":"Ticho","year":"2020","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2025.05.009_bib101","doi-asserted-by":"crossref","first-page":"38477","DOI":"10.1021\/acsomega.4c02999","article-title":"Determination of site-specific phosphorylation occupancy using targeted mass spectrometry reveals the regulation of human apical bile acid transporter, ASBT","volume":"9","author":"Nguyen","year":"2024","journal-title":"ACS Omega"},{"key":"10.1016\/j.jhep.2025.05.009_bib102","doi-asserted-by":"crossref","first-page":"931","DOI":"10.3389\/fphar.2018.00931","article-title":"Ileal bile acid transporter inhibition for the treatment of chronic constipation, cholestatic pruritus, and NASH","volume":"9","author":"Al-Dury","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jhep.2025.05.009_bib103","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S2352-4642(23)00259-6","article-title":"Paediatric research sets new standards for therapy in paediatric and adult cholestasis","volume":"8","author":"Jeyaraj","year":"2024","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.jhep.2025.05.009_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110835","article-title":"ASBT(SLC10A2): a promising target for treatment of diseases and drug discovery","volume":"132","author":"Yang","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jhep.2025.05.009_bib105","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s12072-020-10070-w","article-title":"Ileal bile acid transporter inhibition as an anticholestatic therapeutic target in biliary atresia and other cholestatic disorders","volume":"14","author":"Karpen","year":"2020","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhep.2025.05.009_bib106","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12929-018-0475-8","article-title":"Jaundice revisited: recent advances in the diagnosis and treatment of inherited cholestatic liver diseases","volume":"25","author":"Chen","year":"2018","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.jhep.2025.05.009_bib107","doi-asserted-by":"crossref","first-page":"S-118","DOI":"10.1016\/S0016-5085(22)63519-4","article-title":"Dual ileal\/renal-liver bile acid transporter inhibitors significantly increase urinary excretion of non-sulfated bile acids in a diethoxy-carbonyl-dihydro-collidine-induced mouse model of cholestasis","volume":"162","author":"Rao","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2025.05.009_bib108","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/hep.28396","article-title":"Terlipressin given by continuous intravenous infusion versus intravenous boluses in the treatment of hepatorenal syndrome: a randomized controlled study","volume":"63","author":"Cavallin","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.05.009_bib109","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.05.009_bib110","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1053\/j.gastro.2008.02.024","article-title":"Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study","volume":"134","author":"Mart\u00edn-Llah\u00ed","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2025.05.009_bib111","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1053\/j.gastro.2016.02.026","article-title":"Terlipressin plus albumin is more effective than albumin alone in improving renal function in patients with cirrhosis and hepatorenal syndrome type 1","volume":"150","author":"Boyer","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2025.05.009_bib112","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1053\/gast.2002.32364","article-title":"Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study","volume":"122","author":"Moreau","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2025.05.009_bib113","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1053\/jhep.2002.35819","article-title":"Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study","volume":"36","author":"Ortega","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.05.009_bib114","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1053\/j.gastro.2008.02.014","article-title":"A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome","volume":"134","author":"Sanyal","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2025.05.009_bib115","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.jhep.2013.12.032","article-title":"Terlipressin and albumin for type-1 hepatorenal syndrome associated with sepsis","volume":"60","author":"Rodr\u00edguez","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.05.009_bib116","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00508-023-02229-w","article-title":"Austrian consensus on the diagnosis and management of portal hypertension in advanced chronic liver disease (Billroth IV)","volume":"135","author":"Mandorfer","year":"2023","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.jhep.2025.05.009_bib117","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1002\/hep.30558","article-title":"The renaissance of cholemic nephropathy: a likely underestimated cause of renal dysfunction in liver disease","volume":"69","author":"Mandorfer","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.05.009_bib118","first-page":"92","article-title":"Bile cast nephropathy in patients with acute kidney injury due to hepatorenal syndrome: a postmortem kidney biopsy study","volume":"5","author":"Nayak","year":"2017","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.jhep.2025.05.009_bib119","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1002\/hep.29569","article-title":"A randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis","volume":"67","author":"Kowdley","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.05.009_bib120","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1002\/hep.26018","article-title":"Anticholestatic effects of bezafibrate in patients with primary biliary cirrhosis treated with ursodeoxycholic acid","volume":"57","author":"Honda","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.05.009_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102056","article-title":"Selective PPAR\u03b4 agonist seladelpar suppresses bile acid synthesis by reducing hepatocyte CYP7A1 via the fibroblast growth factor 21 signaling pathway","volume":"298","author":"Kouno","year":"2022","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2025.05.009_bib122","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.jhep.2021.01.013","article-title":"A randomized placebo-controlled trial of elafibranor in patients with primary biliary cholangitis and incomplete response to UDCA","volume":"74","author":"Schattenberg","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.05.009_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2021.101751","article-title":"Effects of odevixibat on pruritus and bile acids in children with cholestatic liver disease: phase 2 study","volume":"45","author":"Baumann","year":"2021","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.jhep.2025.05.009_bib124","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1002\/hep4.1244","article-title":"Placebo-Controlled randomized trial of an intestinal bile salt transport inhibitor for pruritus in Alagille syndrome","volume":"2","author":"Shneider","year":"2018","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhep.2025.05.009_bib125","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/S0140-6736(21)01256-3","article-title":"Efficacy and safety of maralixibat treatment in patients with Alagille syndrome and cholestatic pruritus (ICONIC): a randomised phase 2 study","volume":"398","author":"Gonzales","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2025.05.009_bib126","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/hep.29888","article-title":"Na(+) -taurocholate cotransporting polypeptide inhibition has hepatoprotective effects in cholestasis in mice","volume":"68","author":"Slijepcevic","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.05.009_bib127","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.steroids.2017.07.001","article-title":"Unconjugated bile acids in rat brain: analytical method based on LC\/ESI-MS\/MS with chemical derivatization and estimation of their origin by comparison to serum levels","volume":"125","author":"Higashi","year":"2017","journal-title":"Steroids"},{"key":"10.1016\/j.jhep.2025.05.009_bib128","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/s42255-021-00398-4","article-title":"Central anorexigenic actions of bile acids are mediated by TGR5","volume":"3","author":"Perino","year":"2021","journal-title":"Nat Metab"},{"key":"10.1016\/j.jhep.2025.05.009_bib129","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.cmet.2021.04.009","article-title":"Hypothalamic bile acid-TGR5 signaling protects from obesity","volume":"33","author":"Castellanos-Jankiewicz","year":"2021","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhep.2025.05.009_bib130","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nature04330","article-title":"Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation","volume":"439","author":"Watanabe","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2025.05.009_bib131","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2023.149342","article-title":"Bile acids regulate SF-1 to alter cholesterol balance in adrenocortical cells via S1PR2","volume":"692","author":"Liu","year":"2024","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jhep.2025.05.009_bib132","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1111\/liv.14052","article-title":"Bile acids increase steroidogenesis in cholemic mice and induce cortisol secretion in adrenocortical H295R cells via S1PR2, ERK and SF-1","volume":"39","author":"Liu","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2025.05.009_bib133","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1186\/s12876-021-02045-4","article-title":"Hypercortisolism in patients with cholestasis is associated with disease severity","volume":"21","author":"Theiler-Schwetz","year":"2021","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jhep.2025.05.009_bib134","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/hep.28890","article-title":"Bile acid excess induces cardiomyopathy and metabolic dysfunctions in the heart","volume":"65","author":"Desai","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.05.009_bib135","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1002\/hep4.1890","article-title":"Features of cirrhotic cardiomyopathy early in the lives of infants with biliary atresia correlate with outcomes following kasai portoenterostomy","volume":"6","author":"Morrison","year":"2022","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhep.2025.05.009_bib136","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2011.06.082","article-title":"Cardiac structural and functional alterations in infants and children with biliary atresia, listed for liver transplantation","volume":"141","author":"Desai","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2025.05.009_bib137","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1111\/liv.12438","article-title":"Cardiomyopathy reverses with recovery of liver injury, cholestasis and cholanemia in mouse model of biliary fibrosis","volume":"35","author":"Desai","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2025.05.009_bib138","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1002\/hep.23585","article-title":"Hypertrophic cardiomyopathy and dysregulation of cardiac energetics in a mouse model of biliary fibrosis","volume":"51","author":"Desai","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.05.009_bib139","article-title":"Bile acids induce alterations in mitochondrial function in skeletal muscle fibers","volume":"11","author":"Abrigo","year":"2022","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.jhep.2025.05.009_bib140","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ebiom.2018.10.030","article-title":"Dysregulated bile acid signaling contributes to the neurological impairment in murine models of acute and chronic liver failure","volume":"37","author":"Xie","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jhep.2025.05.009_bib141","article-title":"Systemic ASBT inactivation protects against liver damage in obstructive cholestasis in mice","volume":"4","author":"Kunst","year":"2022","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhep.2025.05.009_bib142","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1053\/j.gastro.2018.06.038","article-title":"An FXR agonist reduces bile acid synthesis independently of increases in FGF19 in healthy volunteers","volume":"155","author":"Al-Khaifi","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2025.05.009_bib143","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jhep.2016.12.005","article-title":"The FXR agonist PX20606 ameliorates portal hypertension by targeting vascular remodelling and sinusoidal dysfunction","volume":"66","author":"Schwabl","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.05.009_bib144","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1038\/s42255-021-00452-1","article-title":"Gut microbiota depletion exacerbates cholestatic liver injury via loss of FXR signalling","volume":"3","author":"Schneider","year":"2021","journal-title":"Nat Metab"},{"key":"10.1016\/j.jhep.2025.05.009_bib145","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/s12276-023-00932-2","article-title":"The role of the farnesoid X receptor in kidney health and disease: a potential therapeutic target in kidney diseases","volume":"55","author":"Kim","year":"2023","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.jhep.2025.05.009_bib146","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jhep.2022.10.023","article-title":"Hepatic and renal improvements with FXR agonist vonafexor in individuals with suspected fibrotic NASH","volume":"78","author":"Ratziu","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.05.009_bib147","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/bcpt.13971","article-title":"The role of peroxisome proliferator-activated receptors in the regulation of bile acid metabolism","volume":"134","author":"Sun","year":"2024","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.jhep.2025.05.009_bib148","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.149360","article-title":"Active enterohepatic cycling is not required for the choleretic actions of 24-norUrsodeoxycholic acid in mice","volume":"8","author":"Truong","year":"2023","journal-title":"JCI Insight"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016882782502207X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016882782502207X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T08:19:53Z","timestamp":1763713193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016882782502207X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":148,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S016882782502207X"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2025.05.009","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enteronephrohepatic circulation of bile acids and therapeutic potential of systemic bile acid transporter inhibitors","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2025.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver.","name":"copyright","label":"Copyright"}]}}